Summary
This clinical-stage biopharmaceutical company focuses on developing innovative T cell therapies aimed at treating cancer. By leveraging insights from patients who have successfully battled cancer, the company aims to create effective treatments for those still fighting the disease. Their approach includes a variety of technologies designed to enhance the immune response against cancer cells.
Link
Link